Literature DB >> 8476425

Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells.

N Yamada1, Y Kawakami, H Kimura, H Fukamachi, G Baier, A Altman, T Kato, Y Inagaki, T Kawakami.   

Abstract

Two novel tyrosine kinase cDNAs were obtained from murine mast cells. These kinases, Emb and Emt, constitute a novel tyrosine kinase subfamily which may also include Tec, a kinase preferentially expressed in liver, and Dsrc28, a fruit fly kinase. Both lack hydrophobic stretches characteristic of the transmembrane domains found in growth factor receptor tyrosine kinases and carboxyl-terminal, negative regulatory tyrosine residue found in Src family kinases. In addition to the Src homology region 2 (SH2) and SH3 domains characteristic of the Src family kinases and other signaling molecules, Emb and Emt share a similar amino-terminal domain comprised mainly of two repeat segments. The emb 2.7-kb transcript was expressed in mast cells, myeloid cells and B lymphocytes while the emt 4.6-kb mRNA in mast cells, myeloid cells and T lymphocytes. The evidence for in vitro tyrosine kinase activity of Emb and Emt proteins is also provided.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476425     DOI: 10.1006/bbrc.1993.1404

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

Review 1.  Early B cell defects.

Authors:  H B Gaspar; M E Conley
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  Posttranscriptional regulation of Bruton's tyrosine kinase expression in antigen receptor-stimulated splenic B cells.

Authors:  S Nisitani; A B Satterthwaite; K Akashi; I L Weissman; O N Witte; M I Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Terreic acid, a quinone epoxide inhibitor of Bruton's tyrosine kinase.

Authors:  Y Kawakami; S E Hartman; E Kinoshita; H Suzuki; J Kitaura; L Yao; N Inagaki; A Franco; D Hata; M Maeda-Yamamoto; H Fukamachi; H Nagai; T Kawakami
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  Disrupting the intermolecular self-association of Itk enhances T cell signaling.

Authors:  Lie Min; Wenfang Wu; Raji E Joseph; D Bruce Fulton; Leslie Berg; Amy H Andreotti
Journal:  J Immunol       Date:  2010-03-17       Impact factor: 5.422

Review 5.  T-cell signaling regulated by the Tec family kinase, Itk.

Authors:  Amy H Andreotti; Pamela L Schwartzberg; Raji E Joseph; Leslie J Berg
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-02       Impact factor: 10.005

6.  Antiviral immune responses in Itk-deficient mice.

Authors:  M F Bachmann; D R Littman; X C Liao
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  B-cell-specific demethylation of BTK, the defective gene in X-linked agammaglobulinemia.

Authors:  O Parolini; J Rohrer; L H Shapiro; M E Conley
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

Review 8.  Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Authors:  J H Hanke; B A Pollok; P S Changelian
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

9.  Itk tyrosine kinase substrate docking is mediated by a nonclassical SH2 domain surface of PLCgamma1.

Authors:  Lie Min; Raji E Joseph; D Bruce Fulton; Amy H Andreotti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

10.  Tyrosine phosphorylation of CD45 phosphotyrosine phosphatase by p50csk kinase creates a binding site for p56lck tyrosine kinase and activates the phosphatase.

Authors:  M Autero; J Saharinen; T Pessa-Morikawa; M Soula-Rothhut; C Oetken; M Gassmann; M Bergman; K Alitalo; P Burn; C G Gahmberg
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.